| Literature DB >> 22805612 |
Dahai Yang1, Qin Liu, Minjun Yang, Haizhen Wu, Qiyao Wang, Jingfan Xiao, Yuanxing Zhang.
Abstract
BACKGROUND: Zebrafish (Danio rerio) is a prominent vertebrate model of human development and pathogenic disease and has recently been utilized to study teleost immune responses to infectious agents threatening the aquaculture industry. In this work, to clarify the host immune mechanisms underlying the protective effects of a putative vaccine and improve its immunogenicity in the future efforts, high-throughput RNA sequencing technology was used to investigate the immunization-related gene expression patterns of zebrafish immunized with Edwardsiella tarda live attenuated vaccine.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22805612 PMCID: PMC3583171 DOI: 10.1186/1471-2164-13-319
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1MA plot of differentially expressed genes identified in WED-immunized and mock-immunized zebrafish livers. Data represent individual gene responses plotted as log2 fold-change versus baseMean fold-change >2 (p-values <0.05), with a negative change representing the down-regulated genes and a positive change representing the up-regulated genes.
Figure 2Significantly up-regulated genes assigned to GO biological process categories.
Statistically significant KEGG classifications of differentially expressed genes
| Ribosome | 70 | 1.53 | 9.60E-14 |
| Proteasome | 35 | 0.77 | 1.80E-13 |
| Protein processing in endoplasmic reticulum | 81 | 1.77 | 2.27E-10 |
| Arginine and proline metabolism | 27 | 0.59 | 2.26E-04 |
| Primary bile acid biosynthesis | 10 | 0.22 | 8.23E-04 |
| Fructose and mannose metabolism | 18 | 0.39 | 2.44E-03 |
| Glycolysis/Gluconeogenesis | 27 | 0.59 | 3.47E-03 |
| N-Glycan biosynthesis | 22 | 0.48 | 3.71E-03 |
| Glycine, serine and threonine metabolism | 15 | 0.33 | 1.64E-02 |
| Galactose metabolism | 13 | 0.28 | 2.23E-02 |
| Histidine metabolism | 12 | 0.26 | 4.02E-02 |
| Peroxisome | 27 | 0.59 | 4.50E-02 |
| Propanoate metabolism | 13 | 0.28 | 4.84E-02 |
| Protein export | 13 | 0.28 | 4.96E-02 |
* indicates the percentage of genes in each pathway from 3467 genes mapped to KEGG.
Significantly differentially expressed genes in acute phase response
| ENSDARG00000069293 | Alpha-2-HS-glycoprotein | 554.80 | 55.81 | −11.84 | 7.26E-50 | |
| ENSDARG00000040298 | Apolipoprotein A-IV | 266.33 | 164.60 | −2.09 | 2.21E-04 | |
| ENSDARG00000012552 | Transferrin receptor (p90, CD71) | 23.29 | 13.29 | −2.27 | 1.18E-04 | |
| ENSDARG00000044612 | Complement component 1, q subcomponent | 6.06 | 3.14 | −2.23 | 6.06E-03 | |
| ENSDARG00000023111 | Plasminogen | 64.66 | 37.99 | −2.18 | 6.73 E-04 | |
| ENSDARG00000058053 | C1 inhibitor | 15.69 | 6.71 | −2.93 | 5.49E-05 | |
| ENSDARG00000019772 | Complement component 2 | 24.57 | 52.88 | 2.06 | 2.99E-10 | |
| ENSDARG00000038424 | Complement C4 | 323.79 | 978.12 | 2.07 | 8.93E-13 | |
| ENSDARG00000055278 | Complement factor B | 727.97 | 1914.46 | 2.09 | 3.38 E-03 | |
| ENSDARG00000045089 | Serum amyloid P component | 309.74 | 872.88 | 2.16 | 1.64 E-04 | |
| ENSDARG00000010312 | Ceruloplasmin (Fragment) | 633.50 | 1737.21 | 2.19 | 2.74 E-03 | |
| ENSDARG00000016319 | Complement component C9 | 18.78 | 48.27 | 2.28 | 4.90E-157 | |
| ENSDARG00000056778 | Complement factor H, like 2 | 11.76 | 38.65 | 2.28 | 6.44E-07 | |
| ENSDARG00000089980 | Transferrin receptor 2 | 10.84 | 34.09 | 2.51 | 2.58 E-04 | |
| ENSDARG00000020741 | Fibrinogen alpha chain | 375.41 | 1118.34 | 2.55 | 4.87E-05 | |
| ENSDARG00000012694 | Complement component c3a | 1305.16 | 4584.02 | 2.77 | 1.21 E-03 | |
| ENSDARG00000087143 | Antitrypsin | 466.41 | 1720.58 | 3.05 | 1.18E-05 | |
| ENSDARG00000043719 | PREDICTED: complement C3-H2-like | 154.97 | 692.50 | 3.44 | 1.19E-08 | |
| ENSDARG00000056795 | Plasminogen activator inhibitor type 1 | 13.14 | 68.84 | 4.38 | 6.20E-14 | |
| ENSDARG00000042725 | CCAAT/enhancer binding protein, beta | 37.33 | 202.58 | 4.42 | 4.58E-13 | |
| ENSDARG00000037281 | Fibrinogen, gamma polypeptide | 154.90 | 965.71 | 5.39 | 6.08E-15 | |
| ENSDARG00000015551 | Ferritin | 180.30 | 1233.87 | 5.45 | 9.51E-14 | |
| ENSDARG00000060012 | Coagulation factor II (Thrombin) receptor | 0.38 | 3.11 | 6.57 | 6.63E-05 | |
| ENSDARG00000071456 | C-reactive protein | 0.37 | 3.41 | 9.71 | 2.46 E-04 | |
| ENSDARG00000003699 | ATPase, Cu++ transporting | 0.21 | 3.99 | 13.09 | 2.38E-06 | |
| ENSDARG00000051912 | Hemopexin | 192.84 | 7565.38 | 31.36 | 3.57E-17 | |
| ENSDARG00000052322 | Toll-like receptor 5 | 2.17 | 98.99 | 36.41 | 7.93E-62 | |
| ENSDARG00000056874 | Lysozyme | 11.85 | 641.71 | 41.37 | 1.70E-41 | |
| ENSDARG00000057121 | Complement component 7 | 6.38 | 435.85 | 63.02 | 4.13E-36 | |
| ENSDARG00000003523 | Intelectin 3 | 52.98 | 8467.17 | 129.02 | 3.93E-33 | |
| ENSDARG00000033227 | Leukocyte cell-derived chemotaxin 2 | 8.75 | 2597.52 | 222.85 | 8.92E-56 | |
| ENSDARG00000051890 | Haptoglobin | 14.36 | 7332.05 | 387.28 | 1.97E-30 | |
| ENSDARG00000045999 | Serum amyloid protein A | 1.24 | 1248.94 | 883.07 | 2.56E-66 |
Identification of all differentially expressed genes was based on p < 0.05. A p-value < 0.05 indicated that the gene was significantly altered in WED immunized fish with respect to mock-immunized fish. The absolute value of “Fold-change” is the magnitude of up- or down-regulation for each gene/homolog after WED immunization. Fold-change > 2 indicates up-regulation, and < −2 indicates down-regulation.
Figure 3Significantly differentially expressed genes identified by KEGG as involved in toll-like receptor signaling. Red: significantly increased expression (fold-change >2); Blue: significantly decreased expression (fold-change <0.5); Green: genes detected both in up- and down-regulated groups; Gray: unchanged expression.
Differentially expressed genes related to the antigen processing and presentation pathways
| ENSDARG00000090851 | MHC class II, transactivator | 0.70 | 0.03 | −26.80 | 5.54E-07 | |
| ENSDARG00000093706 | Beta chain, MHC class II | 2.04 | 0.36 | −7.22 | 3.43E-04 | |
| ENSDARG00000079105 | MHC class II DAB gene | 15.90 | 2.62 | −7.22 | 2.16E-17 | |
| ENSDARG00000055447 | Novel MHC II beta chain protein | 6.12 | 1.70 | −4.33 | 1.70E-06 | |
| ENSDARG00000014914 | Lysosomal membrane glycoprotein 2 | 3.47 | 1.11 | −4.14 | 5.36E-03 | |
| ENSDARG00000036628 | MHC, class II invariant chain, CD74 molecule, | 34.87 | 10.77 | −3.93 | 6.53E-12 | |
| ENSDARG00000043081 | Cathepsin Z | 4.67 | 1.51 | −3.77 | 8.36E-03 | |
| ENSDARG00000074656 | Cathepsin S, b.1 | 23.25 | 10.44 | −2.59 | 4.24E-06 | |
| ENSDARG00000005842 | CD9 antigen | 37.62 | 19.91 | −2.34 | 5.21E-05 | |
| ENSDARG00000003032 | CD68 antigen variant | 472.12 | 258.97 | −2.33 | 1.94E-05 | |
| ENSDARG00000068629 | CD151 antigen, like | 0.71 | 4.88 | 4.80 | 1.16E-03 | |
| ENSDARG00000012234 | Proteasome activator complex subunit 3 | 8.68 | 19.69 | 2.02 | 6.74E-03 | |
| ENSDARG00000053832 | Integral membrane protein 1(STT3) | 121.55 | 311.95 | 2.03 | 6.23E-04 | |
| ENSDARG00000033144 | Proteasome activator PA28 subunit 2 | 10.22 | 25.23 | 2.04 | 1.27E-03 | |
| ENSDARG00000032296 | Proteasome maturation protein | 12.60 | 31.84 | 2.13 | 2.01E-03 | |
| ENSDARG00000058351 | TAP binding protein-like(TAPBPL) | 5.75 | 15.38 | 2.18 | 1.09E-03 | |
| ENSDARG00000002165 | Proteasome activator PA28 subunit 1 | 12.99 | 39.58 | 2.65 | 4.72E-05 | |
| ENSDARG00000037488 | Calnexin | 49.15 | 167.03 | 2.85 | 3.71E-06 | |
| ENSDARG00000026070 | CD82 antigen,b | 5.33 | 19.59 | 2.99 | 5.56E-07 | |
| ENSDARG00000001470 | MHC class I ZE protein | 4.96 | 18.39 | 3.09 | 1.63E-06 | |
| ENSDARG00000075584 | T-cell immunomodulatory protein | 1.74 | 7.16 | 3.21 | 6.74E-07 | |
| ENSDARG00000004754 | Heat shock protein 4a | 5.42 | 18.17 | 3.28 | 9.21E-06 | |
| ENSDARG00000003526 | Proteasome (prosome, macropain) subunit, alpha | 1.90 | 7.52 | 3.60 | 9.48E-04 | |
| ENSDARG00000043276 | ER-resident chaperone calreticulin | 29.97 | 131.43 | 3.72 | 4.47E-10 | |
| ENSDARG00000013938 | Proteasome (prosome, macropain) subunit, beta | 13.34 | 60.15 | 3.80 | 3.27E-09 | |
| ENSDARG00000022652 | Proteasome (prosome, macropain) inhibitor | 3.38 | 15.05 | 3.94 | 1.51E-06 | |
| ENSDARG00000090191 | Proteasome (prosome, macropain) | 2.39 | 11.31 | 4.22 | 6.25E-04 | |
| ENSDARG00000024746 | Heat shock protein HSP 90 kDa alpha 2 | 0.54 | 2.81 | 4.39 | 7.07E-05 | |
| ENSDARG00000043561 | Proteasome (macropain) 26 S subunit | 12.62 | 67.60 | 4.55 | 2.86E-15 | |
| ENSDARG00000021924 | Heat shock cognate 70 kDa protein | 0.24 | 2.13 | 6.67 | 1.06E-05 | |
| ENSDARG00000025147 | CD63 antigen | 32.31 | 296.86 | 7.61 | 4.69E-20 | |
| ENSDARG00000003061 | CD276 molecule | 0.60 | 7.15 | 7.94 | 2.91E-08 | |
| ENSDARG00000089904 | CD97 molecule | 1.40 | 13.32 | 8.03 | 1.35E-31 | |
| ENSDARG00000003570 | Endoplasmin (grp94) | 93.60 | 1118.80 | 10.06 | 2.85E-18 | |
| ENSDARG00000059327 | GATA-binding protein 2a | 0.08 | 1.04 | 12.76 | 8.73E-03 | |
| ENSDARG00000007836 | Cathepsin L, 1 a | 20.92 | 340.42 | 13.53 | 1.98E-43 | |
| ENSDARG00000015088 | DnaJ (Hsp40) homolog, subfamily B | 3.42 | 61.99 | 15.13 | 1.19E-32 |
Identification of all differentially expressed genes was based on p<0.05. A p-value<0.05 indicated that the gene was significantly altered in WED-immunized fish with respect to mock-immunized fish. The absolute value of “Fold-change” is the magnitude of up- or down-regulation for each gene/homolog after WED immunization. Fold-change > 2 indicates up-regulation, and < −2 indicates down-regulation.
Figure 4Significantly differentially expressed genes identified by KEGG as involved in antigen processing and presentation. Red: significantly increased expression (fold-change >2); Blue: significantly decreased expression (fold-change <0.5); Green: genes detected both in up- and down-regulated groups; Gray: unchanged expression.
Figure 5qPCR analysis of the genes related to MHC-I processing pathway in zebrafish following WEDimmunization during the first five days. Proteasome activator (PA28), heat shock protein 90 kDa alpha (HSP90α), heat shock protein 4a (HSPa4a), endoplasmin (grp94), TAP binding protein (tapbpl), calreticulin (calr), calnexin (canx) and MHC class I ZE protein (MHC-I) were validated. The relative expression of the above immune-related genes in livers (gray bars) and spleens (white bars) of zebrafish were analyzed by qPCR. Zebrafish were vaccinated via intramuscular injection with WED or PBS. The livers and spleens of 10 fish were taken at 1, 2, 3, 5 d post-vaccination, respectively, and total RNA was extracted and used for qPCR. The mRNA level of each immune-related gene was normalized to that of β-actin. For the gene of each time point, values represent fold change in expression compared to the control treatment, which was set at 1.0. Results are expressed as means ± SD (n = 3). Mock immunized group was subtracted from each group. Independent-sample t-test in the SPSS software (Version 11.5, SPSS Inc.) was used to determine statistical significance of the WED immunized groups relative to mock groups. Significant differences were considered at * p < 0.01.
Figure 6qPCR analysis of the genes related to MHC-II processing pathway in zebrafish following WEDimmunization during the first five days. Lysosomal membrane glycoprotein 2 (lamp2), MHC class II DAB gene (MHC-II dab), CD74 molecule (cd74) and MHC class II, transactivator (CIITA) were validated. qPCR analysis for the expressions of the above immune-related genes in livers (gray bars) and spleens (white bars) of zebrafish vaccinated with WED. The experimental procedure was the same as in the legend of Figure 5.